Structure-activity relationship of fluoroquinolone inEscherichia coli

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Archives of pharmacal research

• Publication date

  1998-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF02974013PMID 9875416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure/activity relationships

  1998cited by this paper
• Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae

  1996cited by this paper
• N-1-tert-butyl-substituted quinolones: in vitro anti-Mycobacterium avium activities and structure-activity relationship studies

  1996cited by this paper
• Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones

  1996cited by this paper
• Quinolones: structure-activity relationships and future predictions.

  1996cited by this paper
• Norfloxacin resistance mechanism ofE. coli 11 andE. coli 101-clinical isolates ofEscherichia coli in Korea

  1996cited by this paper
• Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa

  1995cited by this paper
• Placement of alkyl substituents on the C-7 piperazine ring of fluoroquinolones: dramatic differential effects on mammalian topoisomerase II and DNA gyrase

  1994cited by this paper
• Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli

  1993cited by this paper
• Quinolone antimicrobial agents

  1993cited by this paper
• Structure-activity relationships of the fluoroquinolones

  1989cited by this paper
• Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug--DNA binding model.

  1989cited by this paper
• Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli

  1986cited by this paper
• The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

  1985cited by this paper

• Effect of WQ-3334 on Campylobacter jejuni carrying a DNA gyrase with dominant amino acid substitutions conferring quinolone resistance.

  2024cites this paper
• The Impact of Substitutions at Positions 1 and 8 of Fluoroquinolones on the Activity Against Mutant DNA Gyrases of Salmonella Typhimurium

  2023cites this paper
• WQ-3810 exerts high inhibitory effect on quinolone-resistant DNA gyrase of Salmonella Typhimurium

  2019cites this paper
• Bicyclic 6-6 systems with one bridgehead (ring junction) nitrogen atom: One extra heteroatom 1:0

  2008cites this paper
• Anti-Inflammatory Effects of Besifloxacin, a Novel Fluoroquinolone, in Primary Human Corneal Epithelial Cells

  2008cites this paper
• Nonclinical Pharmacodynamics, Pharmacokinetics, and Safety of BOL-303224-A, a Novel Fluoroquinolone Antimicrobial Agent for Topical Ophthalmic Use

  2007cites this paper
• Recent Development in the Chemistry of Pyrido-oxazines, Pyrido-thiazines, Pyrido-diazines and Their Benzologs: Part 1

  2003cites this paper
• Ofloxacin-Loaded Liposomes: In Vitro Activity and Drug Accumulation in Bacteria

  2000cites this paper